News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hospira, Inc. (HSP) In Hot Water As FDA Formally Slaps Indian Plant With Warning


12/27/2013 7:00:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The US Food and Drug Administration (FDA) has served a Form 483 - a list of objectionable conditions identified during its inspection -to Hospira Inc's pharmaceutical manufacturing facility at Irungattukottai, Sriperumbudur, near here. The FDI is the regulator for all drugs sold in the US. The company said the observations were primarily related to processes and procedures and it would address the issue in the next several weeks. In a filing with the United States Securities and Exchange Commission, Hospira said the FDA had completed an inspection of the Irungattukottai facility on December 10.

Help employers find you! Check out all the jobs and post your resume.

Read at Business Standard
Read at Chicago Business
Read at News Release
Read at MassDevice

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES